Results 121 to 130 of about 1,121 (144)

Clinical Utility of the aMAP Risk Score for Predicting the Recurrence of Hepatic Encephalopathy After Rifaximin Treatment in Patients With Liver Cirrhosis: A Retrospective Cohort Study

Hepatology Research
ABSTRACT Backgrounds This study aimed to investigate the incidence and potential risk factors for hepatic encephalopathy (HE) recurrence following the initiation of rifaximin therapy in patients with liver cirrhosis. Methods
Kazuko Kizawa, Kyoko Marubashi, Satoshi Takakusagi   +2 more
exaly   +3 more sources

GALAD score outperforms aMAP and ALBI scores in the 5- and 10-year prediction of hepatocellular carcinoma (HCC) development in patients with compensated advanced chronic liver disease (cACLD): a 12-year prospective study

Journal of Hepatology, 2023
Baldaccini, Valentina, Ascari, Sara, Critelli, Rosina Maria, Pesole, Letizia, Lasagni, Simone, Coletta, Sergio, Tedesco, Calogero Claudio, Pasculli, Giuseppe, Donghia, Rossella, Semellini, Filippo, Villa, Erica, Giannelli, Gianluigi   +11 more
openaire   +2 more sources

[Predictive value of aMAP risk score for early recurrence of small hepatocellular carcinoma after microwave ablation].

Zhonghua nei ke za zhi, 2023
Objective: To explore the value of the aMAP risk score (age, male, albumin-bilirubin, and platelets) to predict early recurrence within one year after microwave ablation in patients with small hepatocellular carcinoma. Methods: This was a retrospective study that enrolled 142 patients diagnosed with hepatocellular carcinoma who were treated with ...
S Y, Dong, S Y, Deng, R, Fan, J Z, Chen, X, Cheng, X, Hao, W C, Dai   +6 more
openaire   +1 more source

Baseline cirrhosis in addition to the aMAP score, increased the risk of developing hepatocellular carcinoma in patients with hepatitis B

Journal of Hepatology, 2023
Supakorn Chaiwiriyawong, Pimsiri Sripongpun, Naichaya Chamroonkul, Apichat Kaewdech   +3 more
openaire   +1 more source

P70 HCC surveillance in a nurse-led clinic: assessing adherence to guidelines and possible role of aMAP score

Poster presentations, 2022
Mohamed Elnagar, Muhammad Saleem, Alison Beard, Samantha Whyld, Andrew Austin   +4 more
openaire   +1 more source

Sa1602 THE UTILITY OF AMAP SCORE IN PREDICTING HEPATOCELLULAR CARCINOMA RISK IN PATIENTS WITH ADVANCED NON-ALCOHOLIC FATTY LIVER DISEASE

Gastroenterology, 2023
Chinmay Bera, Heather M. Kosick, Mohamed Shengir, Oyedele Adeyi, Giada Sebastiani, Keyur Patel   +5 more
openaire   +1 more source

aMAP score and its combination with liver stiffness measurement accurately assess liver fibrosis in virologically suppressed CHB patients

Journal of Hepatology, 2023
Rong Fan, Guanlin Li, Ning Yu, Xiu-Juan Chang, Tamoore Arshad, Wen-Yue Liu, Yan Chen, Grace Lai-Hung Wong, Yiyue Jiang, Xieer Liang, Yongpeng Chen, Xiao-Zhi Jin, Zheng Dong, Howard Ho-Wai Leung, Xiaodong Wang, Zhen Zeng, Terry Cheuk-Fung Yip, Qing Xie, Deming Tan, Shaoli You, Dong Ji, Jun Zhao, Arun Sanyal, Jian Sun, Ming-Hua Zheng, Vincent Wai-Sun Wong, Yongping Yang, Jinlin Hou   +27 more
openaire   +1 more source

Risk‐stratified approach by aMAP score for community population infected with hepatitis B and C to guide subsequent liver cancer screening practice: A cohort study with 10‐year follow‐up

Journal of Viral Hepatitis, 2023
Hua He, Zhifang Jia, Yuchen Pan
exaly  

Validation of the aMAP score to predict hepatocellular carcinoma development in a cohort of alcohol‐related cirrhosis patients

Liver Cancer International, 2022
Ken Liu, Terry Cheuk-Fung Yip, Steven Masson   +2 more
exaly  

Validation of the hepatocellular carcinoma early detection screening algorithm Doylestown and aMAP in a cohort of Chinese with cirrhosis

Journal of Clinical Laboratory Analysis, 2022
Yunsong Qian, Linhong Li, Rengbin Ji
exaly